These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7886656)

  • 1. Effectiveness of nebulised salbutamol administered in ambulances to patients with severe acute asthma.
    Fergusson RJ; Stewart CM; Wathen CG; Moffat R; Crompton GK
    Thorax; 1995 Jan; 50(1):81-2. PubMed ID: 7886656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous beta agonist in severe acute asthma.
    Cheong B; Reynolds SR; Rajan G; Ward MJ
    BMJ; 1988 Aug; 297(6646):448-50. PubMed ID: 3139138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction.
    O'Driscoll BR; Taylor RJ; Horsley MG; Chambers DK; Bernstein A
    Lancet; 1989 Jun; 1(8652):1418-20. PubMed ID: 2567431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing half the message? A re-audit of the care of patients with acute asthma by emergency ambulance crews in London.
    Snooks H; Halter M; Palmer Y; Booth H; Moore F
    Qual Saf Health Care; 2005 Dec; 14(6):455-8. PubMed ID: 16326794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adding aminophylline infusion to nebulised salbutamol in severe acute asthma.
    Zainudin BM; Ismail O; Yusoff K
    Thorax; 1994 Mar; 49(3):267-9. PubMed ID: 8202885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, prospective comparison of beta 2 agonists given via nebuliser, Nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment.
    Campbell IA; Colman SB; Mao JH; Prescott RJ; Weston CF
    Thorax; 1995 Jan; 50(1):79-80. PubMed ID: 7886655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulised adrenaline in acute severe asthma: comparison with salbutamol.
    Coupe MO; Guly U; Brown E; Barnes PJ
    Eur J Respir Dis; 1987 Oct; 71(4):227-32. PubMed ID: 3691679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
    Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma.
    Nannini LJ; Pendino JC; Corna RA; Mannarino S; Quispe R
    Am J Med; 2000 Feb; 108(3):193-7. PubMed ID: 10723972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nebulised magnesium sulphate and salbutamol combined with salbutamol alone in the treatment of acute bronchial asthma: a randomised study.
    Aggarwal P; Sharad S; Handa R; Dwiwedi SN; Irshad M
    Emerg Med J; 2006 May; 23(5):358-62. PubMed ID: 16627836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial.
    Hughes R; Goldkorn A; Masoli M; Weatherall M; Burgess C; Beasley R
    Lancet; 2003 Jun; 361(9375):2114-7. PubMed ID: 12826434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children.
    Browne GJ; Penna AS; Phung X; Soo M
    Lancet; 1997 Feb; 349(9048):301-5. PubMed ID: 9024371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of a bodyweight dose versus a fixed dose of nebulised salbutamol in acute asthma in children.
    Oberklaid F; Mellis CM; Souëf PN; Geelhoed GC; Maccarrone AL
    Med J Aust; 1993 Jun; 158(11):751-3. PubMed ID: 8341188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").
    Newnham DM; Lipworth BJ
    Thorax; 1994 Aug; 49(8):762-70. PubMed ID: 8091320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.
    Zainudin BM; Tolfree SE; Short M; Spiro SG
    Thorax; 1988 Dec; 43(12):987-91. PubMed ID: 3238642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of change in oxygen saturation and peak expiratory flow in children admitted to hospital with acute asthma.
    Mihatsch W; Geelhoed GC; Landau LI; LeSouëf PN
    Thorax; 1990 Jun; 45(6):438-41. PubMed ID: 2392787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial.
    Goodacre S; Cohen J; Bradburn M; Gray A; Benger J; Coats T;
    Lancet Respir Med; 2013 Jun; 1(4):293-300. PubMed ID: 24429154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic regimes for acute bronchial asthma.
    Anantharaman V
    Singapore Med J; 1993 Dec; 34(6):534-7. PubMed ID: 8153718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children with asthma: will nebulised salbutamol reduce hospital admissions?
    Pearce JL; Wesley HM
    Br Med J (Clin Res Ed); 1985 Feb; 290(6468):595-7. PubMed ID: 3918686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.